GenePeeks and Alliance Global Group (AGBL) Sign Distribution Agreement for Middle East and Africa

genepeeks-logoAlliance Global Group (AGBL) partners with Genepeeks to bring their innovative solutions for comprehensive preconception screening to patients, healthcare providers and laboratories in the Middle Eastern and African regions.

Dr. Tamer Degheidy, Group CEO at Alliance Global stated, “GenePeeks Preconception Screen is an important addition to our growing portfolio of genetic tests, and we’re excited to offer this comprehensive, state-of-the art approach, which reduces the population biases that are associated with traditional carrier screening. It is the first step in our shared mission to transform gene-based clinical applications using GenePeeks’ core technology platform.”

“We are honored to partner with Alliance Global to address the significant unmet need in these markets for comprehensive preconception screening,” said Anne Morriss, Co-Founder and Chief Executive Officer of GenePeeks. “AGBL’s regional breadth and market knowledge, combined with the analytic power of our advanced computational platform, will give more prospective parents the information and support they need to protect their future families. AGBL is another strong partner for our growing presence outside of the U.S.”

Read the entire Press Release here.